March 2nd, 2011
IP Trends and Successful Practices
March 2nd, 2011
David Feinleib of Mohr Davidow Ventures will lead a discussion about the components of a compelling business proposal and what you can expect from a venture investor.
February 28th, 2011
The ARPA-E Energy Innovation Summit 2011 will convene the key players in the nation's energy innovation community to spur the networks that will bring about the next Industrial Revolution in clean energy technologies, in the way the U.S. has led previous revolutions in life sciences and information technology. Participants will include the nation's leading individuals and organizations in energy innovation, including: venture capital investors, technology entrepreneurs, large and small corporations with an interest in clean energy technologies, policymakers from the Administration and Congress, and government officials from the Department of Energy and ARPA-E.
February 24th, 2011
The Entrepreneur and Investor Roundtables is a unique event designed to facilitate introductions, dialogue and connections between life science entrepreneurs and investors. This event provides early stage companies with an accessible first step into capital markets while providing investors a first look at intriguing innovations. The Entrepreneur and Investor Roundtables event is well known for its iconic ‘speed-dating’ format. Each year, VC firms and Angel Investors listen to brief pitches from dozens of biotech entrepreneurs.
February 7th, 2011
An incredible innovation story has been unfolding in genetic sequencing, which is giving rise to one of today’s grand challenges of computing. New DNA sequencing tools in development are said to have enough horsepower to decipher the complete 3-billion-letter signature of an individual’s DNA for under $1,000, and possibly with as little as 15 minutes of work. If this can be done on a large scale, scientists hope it will create an enormously deep set of information to clear the way for a more personalized brand of medicine.
February 4th, 2011
Energy storage has an opportunity to be a game changer in the electricity industry. This panel will explore the developments in energy storage technologies and what needs to happen to make the technologies commercially viable.
January 21st, 2011
Beyond Sequencing: Managing Resources and Maintaining NGS Platforms for Peak Performance
January 17th, 2011
Ten years have passed since the first human genome was sequenced and the era of personalized molecular medicine was ushered in with great fanfare. The principal promise was and is simple: the right drug for the right patient at the right dose. Another equally compelling benefit is more efficient drug development. To date, this promise remains largely unrealized. This panel discussion will examine why and how personalized medicine can realize its promise.


December 15th, 2010
On December 15th, a group of America’s leading policy think tanks will host a day-long conference in Washington D.C. to rethink energy innovation. Energy Innovation 2010, held at the National Press Club, will bring together leading experts from government, think tanks, academia, and business to ask hard questions about how energy innovation efforts can be brought to scale, how the innovation system must be restructured and reformed, and how to renew the kind of active partnerships between the public and private sectors that were responsible for so much of America’s prior technological innovation and economic strength.
December 10th, 2010
Chaired by Richard Katz, M.D., of the George Washington University and Jay Wohlgemuth, M.D., of Quest Diagnostics Nichols Institute, the event will be held at George Washington University on January 6, 2011. It is supported and/or co-sponsored by the Personalized Medicine Coalition (PMC), American College of Cardiology (ACC), American Medical Association (AMA), National Heart Lung and Blood Institute (NHLBI), and the Cheney Cardiovascular Institute at George Washington University (GWU). A superb group of speakers, noted in the program agenda below, has been assembled for the conference. At the conference, ACC will release the results of survey research looking at the adoption of personalized medicine and pharmacogenomic concepts and products in cardiovascular practice. The survey will provide new insights into the rate of adoption of personalized medicine among U.S. cardiologists.